News
Latest News
Sign up for Newsletter
Latest News

Entries for January 2012

New prognostic test for improved cancer treatment
New prognostic test for improved cancer treatment
January 31, 2012
Researchers at the Oslo University Hospital have developed a gene signature that is suitable to be developed into a prognostic test for patients with stage II colorectal cancer. The test has bee... » Read more...

Targovax secures funding for cancer vaccine
Targovax secures funding for cancer vaccine
January 30, 2012
Targovax has secured almost 13 MNOK (2.2 MUSD) from the Radium Hospital Research Foundation, Birk Venture, RO Invest and existing owners for further development of a cancer vaccine against pancreas ca... » Read more...

Tone Yrvum has resigned from her position
Tone Yrvum has resigned from her position
January 30, 2012
Tone Yrvum has announced that she resign her position as Chief Executive Officer of Oslo Cancer Cluster to explore new challenges.  

Nordic Nanovector Raises 14.3 MNOK
Nordic Nanovector Raises 14.3 MNOK
January 25, 2012
Oslo Cancer Cluster member Nordic Nanovector recently announced that the company has raised 14.3 million NOK in gross proceeds through a private placement. The company are developing innovat... » Read more...

Kick-off for targeted cancer program
Kick-off for targeted cancer program
January 24, 2012
The research group Norwegian Cancer Genomics Consortium (NCGC) has sought funding for a three-year research project to study genetic changes in cancer tumors. Oslo Cancer Cluster is supporting this in... » Read more...

BerGenBio raises $9 million
BerGenBio raises $9 million
January 10, 2012
BerGenBio AS, an emerging oncology biopharma company, today announced it has completed an $8.8 million Series A financing round. The financing will be used primarily to take lead compound BGB324 into ... » Read more...

"Bioteknologi for Dummies"
"Bioteknologi for Dummies"
January 03, 2012
Jobber du med bioteknologi, men mangler kunnskap om biologi? Eller har du lyst til å lære mer om et spennende og viktig fagfelt i utvikling? I begge tilfeller er Forskerfabrikkens kurs i bioteknologi ... » Read more...

Upcoming eventsFacebookTwitterBlogVideo
Tuesday, April 29, 2014 1:30 PM
Wednesday, May 07, 2014 8:30 AM
Wednesday, May 14, 2014 1:00 PM
Tuesday, May 20, 2014 11:00 AM
Oslo Cancer Cluster · Vollsveien 6, 1366 Lysaker · Fax: +47 67 12 26 58 · E-mail: mbl@oslocancercluster.no
Designet og utviklet av Rim Idé & kommunikasjon